comparemela.com

Page 3 - Brendan Antiochos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SEMAPHORE: Tocilizumab reduces disease activity in steroid-dependent polymyalgia rheumatica

Tocilizumab may significantly reduce disease activity and the amount of prednisone needed by people with glucocorticoid-dependent polymyalgia

United statesBrendan antiochosJohns hopkinsHealth assessment questionnaire disability indexDevauchelle pensec brest university hospitalBrest university hospitalHealth assessment questionnaire disability

Is PMR the Next Indication for Tocilizumab?

Phase III data suggest yes, albeit in a limited population and with several cautions

Antiochosb tocilizumabBrendan antiochosJohn geverJohns hopkins university in baltimoreHealth assessment questionnaireJohns hopkins universityManaging editor

vimarsana © 2020. All Rights Reserved.